共 525 条
- [71] Jackson D(2006)Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/ II multicenter, controlled, multidose study Ophthalmology 113 633-115
- [72] Cao J(2009)Therapeutic monoclonal antibodies in ophthalmology Prog Retin Eye Res 28 117-805
- [73] Radziejewski C(2011)Anti-VEGF treatment of corneal neovascularization Ocul Surf 9 227-1382
- [74] Klettner A(2010)Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model Curr Eye Res 35 108-85
- [75] Roider J(2009)Bevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse cornea BMB Rep 42 800-66
- [76] Goldman J(2009)Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization Graefes Arch Clin Exp Ophthalmol 247 1375-213
- [77] Rutkowski JM(2010)The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency Invest Ophthalmol Vis Sci. 51 6277-4659
- [78] Shields JD(2011)Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition Cornea 30 60-e38
- [79] Pasquier MC(2014)Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization Arq Bras Oftalmol 77 209-1349
- [80] Cui Y(2009)Bevacizumab application delays epithelial healing in rabbit cornea Invest Ophthalmol Vis Sci 50 4653-83